From the Department of Surgery, Maasstad Hospital, Rotterdam.
Department of Surgery, Amsterdam University Medical Center, Amsterdam.
J Clin Rheumatol. 2022 Mar 1;28(2):77-83. doi: 10.1097/RHU.0000000000001807.
Rheumatoid arthritis (RA) of the wrist can lead to loss of wrist function and progressive joint destruction if inadequately treated. Arthroscopic synovectomy of the wrist may prove a valuable treatment for local inflammation.
The aim of this study was to perform a systematic review evaluating functional outcomes and pain following arthroscopic synovectomy of the wrist in RA patients.
A systematic review was performed according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-analysis) guidelines. MEDLINE, EMBASE, The Cochrane Library, Web of Science, and Google Scholar were searched for studies describing pain or functional outcomes following arthroscopic synovectomy of the wrist in RA patients (CRD42021270846). Risk of bias was assessed using the Methodological Index for Non-Randomized Studies. Data collection included patient characteristics, pain scores, wrist function questionnaires, secondary surgery, and complications.
Six noncomparative cohort studies were included, with a total of 153 arthroscopic synovectomies. Disease duration of RA ranged from 32 to 89 months, and radiographic progression was mild to moderate. The Methodological Index for Non-Randomized Studies scores ranged from 8 to 10 out of 16. Mean follow-up ranged from 21 to 95 months. Improvements were seen in pooled mean visual analog scale pain score (from 7.7 to 2.2, p < 0.05), pooled mean Modified Mayo Wrist Score (from 43.3 to 70.4, p < 0.05), and the Disability of the Arm, Shoulder, and Hand (from 67.5 to 36.5, p < 0.05). Two complications occurred, and 5 patients required secondary surgery.
There is limited evidence suggesting that arthroscopic synovectomy of the wrist improves wrist function and pain in patients with RA, with few complications. In centers with arthroscopic expertise, it can be considered as a treatment option.
类风湿关节炎(RA)手腕如果治疗不当,可能导致手腕功能丧失和进行性关节破坏。腕关节关节镜滑膜切除术可能是治疗局部炎症的有效方法。
本研究旨在对 RA 患者腕关节关节镜滑膜切除术后的功能结果和疼痛进行系统评价。
根据 PRISMA(系统评价和荟萃分析的首选报告项目)指南进行系统评价。检索 MEDLINE、EMBASE、Cochrane 图书馆、Web of Science 和 Google Scholar,以获取描述 RA 患者腕关节关节镜滑膜切除术后疼痛或功能结果的研究(CRD42021270846)。使用非随机研究方法学指数评估偏倚风险。数据收集包括患者特征、疼痛评分、腕关节功能问卷、二次手术和并发症。
纳入 6 项非对照队列研究,共 153 例腕关节关节镜滑膜切除术。RA 疾病持续时间为 32 至 89 个月,放射学进展为轻度至中度。非随机研究方法学指数评分范围为 16 分中的 8 至 10 分。平均随访时间为 21 至 95 个月。汇总平均视觉模拟评分疼痛评分(从 7.7 降至 2.2,p < 0.05)、汇总平均改良 Mayo 腕关节评分(从 43.3 降至 70.4,p < 0.05)和上肢残疾问卷(从 67.5 降至 36.5,p < 0.05)均有改善。发生了 2 例并发症,5 例患者需要二次手术。
有限的证据表明,腕关节关节镜滑膜切除术可改善 RA 患者的腕关节功能和疼痛,并发症较少。在具有关节镜专业知识的中心,可将其视为一种治疗选择。